Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
Biostax Market Cap
Biostax has a market cap or net worth of $10.71 thousand as of March 5, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
10.71K
Enterprise Value
1.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 14, 2012, Biostax's market cap has decreased from 377.40K to 10.71K, a decrease of -97.16%. That is a compound annual growth rate of -22.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 10.71K | -99.20% |
| Dec 31, 2024 | 1.34M | -78.10% |
| Dec 28, 2023 | 6.11M | -87.74% |
| Dec 30, 2022 | 49.83M | 3,358.09% |
| Dec 30, 2021 | 1.44M | -78.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| Q BioMed | 14.51K |
| Virpax Pharmaceuticals | 13.30K |
| ObsEva | 11.72K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Entia Biosciences | 10.22K |